RightAir is developing noninvasive ventilators specifically designed for patients with Chronic Obstructive Pulmonary Disease (COPD). These devices aim to enhance respiratory support without the need for invasive procedures, improving patient comfort and quality of life.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with Chronic Obstructive Pulmonary Disease (COPD) often require respiratory support, traditionally delivered through invasive ventilation methods that can cause discomfort and complications. Existing non-invasive ventilation options may not be specifically tailored to the unique respiratory needs of COPD patients.
Solution
RightAir is creating non-invasive ventilators engineered to provide optimized respiratory support for individuals with COPD. These devices aim to improve patient comfort and quality of life by delivering personalized ventilation without the risks associated with intubation or tracheostomy. The ventilators are designed to adapt to the specific breathing patterns and lung mechanics of COPD patients, ensuring effective gas exchange and reduced respiratory muscle fatigue. By offering a less intrusive alternative, RightAir seeks to enhance adherence to therapy and improve long-term outcomes for individuals managing COPD.
Target Audience
The primary target audience includes COPD patients requiring respiratory support, pulmonologists, respiratory therapists, and hospitals specializing in pulmonary care.
Features
- Personalized ventilation modes tailored to COPD patient physiology
- Real-time monitoring of respiratory parameters for adaptive support
- Integrated humidification and oxygen delivery system
- User-friendly interface for easy setup and operation
- Portable design for use in both clinical and home settings